pyrroles has been researched along with Cells, Neoplasm Circulating in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (17.65) | 29.6817 |
| 2010's | 13 (76.47) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Chow, Z; Evers, BM; Johnson, J; Lee, E; Rychahou, P; Weiss, HL | 1 |
| Ishikawa, S; Katagiri, A; Kazama, A; Mizusawa, T | 1 |
| Horie, S; Kanayama, M; Nagata, M; Nagaya, N | 1 |
| Chai, ZT; Gao, DM; Kong, LQ; Lu, L; Sun, HC; Tang, ZY; Wang, L; Wang, WQ; Wu, WZ; Xu, HX; Zhang, JB; Zhang, W; Zhu, XD; Zhuang, PY | 1 |
| Garcia-Donas, J; Jonasch, E; Rodriguez-Antona, C | 1 |
| Ahn, H; Hong, JH; Jeong, IG; Kim, CS; Kwon, T; Lee, JL; Song, C; You, D | 1 |
| Chi, J; Dong, X; Gu, Q; Ji, R; Jia, X; Leng, X; Li, J; Liu, F; Ma, Y; Sun, B; Sun, R; Zhang, C; Zhang, D; Zhao, X | 1 |
| Khoo, BL; Kumar, P; Lee, SC; Lim, CT; Nandi, S; Ow, SG; Tan, TZ; Thiery, JP; Warkiani, ME | 1 |
| Shibuya, M | 1 |
| Gajda, M; Kroeger, N; Petersen, I; Settmacher, U; Steiner, T; Wunderlich, H; Zanow, J | 1 |
| Beutel, G; Ganser, A; Gruenwald, V; Haubitz, M; Ivanyi, P; Reuter, C; Schuch-Jantsch, S | 1 |
| de Wijn, R; Flatmark, K; Fodstad, Ø; Folkvord, S; Rasmussen, H; Ree, AH; Saelen, MG | 1 |
| Fingerle, A; Gschwend, JE; Hauner, K; Horn, T; Kübler, HR; Maurer, T; Retz, M; Schulz, S; Thalgott, MK | 1 |
| Aieta, M; Amadori, A; Barile, C; Basso, U; Borin, M; Celadin, R; Cristofanilli, M; Fassan, M; Grassi, A; Indraccolo, S; Jirillo, A; Lanza, C; Miatello, L; Rossi, E; Rugge, M; Sava, T; Troiani, L; Zamarchi, R; Zilio, F | 1 |
| Arstrand, K; Johansson, M; Kågedal, B; Lenner, L; Takasaki, A | 1 |
| Staehler, M | 1 |
2 review(s) available for pyrroles and Cells, Neoplasm Circulating
| Article | Year |
|---|---|
Molecular markers to predict response to therapy.
Topics: Antibodies, Monoclonal, Humanized; Antigens, Neoplasm; Bevacizumab; Biomarkers, Tumor; Carbonic Anhydrase IX; Carbonic Anhydrases; Carcinoma, Renal Cell; Gene Dosage; Humans; Immunotherapy; Indazoles; Indoles; Kidney Neoplasms; Mutation; Neoplastic Cells, Circulating; Niacinamide; Phenylurea Compounds; Phosphatidylinositol 3-Kinases; Polymorphism, Genetic; Pyrimidines; Pyrroles; Sorafenib; Sulfonamides; Sunitinib; TOR Serine-Threonine Kinases; Von Hippel-Lindau Tumor Suppressor Protein | 2013 |
Angiogenesis regulated by VEGF and its receptors and its clinical application.
Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzenesulfonates; Bevacizumab; Drug Design; Humans; Indoles; Neoplasms; Neoplastic Cells, Circulating; Neovascularization, Pathologic; Neovascularization, Physiologic; Niacinamide; Phenylurea Compounds; Pyridines; Pyrroles; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Signal Transduction; Sorafenib; Sunitinib; Vascular Endothelial Growth Factor A | 2009 |
15 other study(ies) available for pyrroles and Cells, Neoplasm Circulating
| Article | Year |
|---|---|
Role of AMPK and Akt in triple negative breast cancer lung colonization.
Topics: AMP-Activated Protein Kinases; Animals; Apoptosis; Cell Line, Tumor; Energy Metabolism; Female; Heterocyclic Compounds, 3-Ring; Humans; Lung Neoplasms; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasm Invasiveness; Neoplastic Cells, Circulating; Proto-Oncogene Proteins c-akt; Pyrimidines; Pyrroles; RNA Interference; RNA, Small Interfering; Signal Transduction; Triple Negative Breast Neoplasms | 2021 |
Continuous remission of renal cell carcinoma with tumour thrombus after severe adverse events following short-term treatment with sunitinib.
Topics: Antineoplastic Agents; Carcinoma, Renal Cell; Humans; Indoles; Kidney Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplastic Cells, Circulating; Pyrroles; Remission Induction; Sunitinib; Thrombosis; Vena Cava, Inferior | 2017 |
The Surge in the Number of Circulating Tumor Cells Following Treatment with Sunitinib for Metastatic Renal Cell Carcinoma.
Topics: Aged; Antineoplastic Agents; Biomarkers, Tumor; Carcinoma, Renal Cell; Cell Count; Female; Fluorescent Antibody Technique; Humans; Indoles; Kidney Neoplasms; Neoplastic Cells, Circulating; Pyrroles; Sunitinib | 2018 |
Antiangiogenic therapy promoted metastasis of hepatocellular carcinoma by suppressing host-derived interleukin-12b in mouse models.
Topics: Angiogenesis Inhibitors; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Dendritic Cells; Diphosphonates; Heterografts; Humans; Imidazoles; Immunosuppression Therapy; Indoles; Interleukin-12 Subunit p40; Killer Cells, Natural; Liver Neoplasms; Lung Neoplasms; Macrophages; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Neoplasm Transplantation; Neoplastic Cells, Circulating; Neovascularization, Pathologic; Niacinamide; Phenylurea Compounds; Pyrroles; Receptors, Vascular Endothelial Growth Factor; Sorafenib; Sunitinib; Zoledronic Acid | 2013 |
Impact of surgery on the prognosis of metastatic renal cell carcinoma with IVC thrombus received TKI therapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Renal Cell; Chemotherapy, Adjuvant; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Indazoles; Indoles; Kidney Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplastic Cells, Circulating; Nephrectomy; Niacinamide; Phenylurea Compounds; Prognosis; Proportional Hazards Models; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Retrospective Studies; Sorafenib; Sulfonamides; Sunitinib; Survival Analysis; Thrombectomy; Treatment Outcome; Vena Cava, Inferior; Venous Thrombosis | 2014 |
Twist1 expression induced by sunitinib accelerates tumor cell vasculogenic mimicry by increasing the population of CD133+ cells in triple-negative breast cancer.
Topics: AC133 Antigen; Adult; Aged; Angiogenesis Inhibitors; Animals; Antigens, CD; Cell Line, Tumor; Female; Gene Expression Regulation, Neoplastic; Glycoproteins; Humans; Hypoxia; Indoles; MCF-7 Cells; Mice; Mice, Nude; Middle Aged; Neoplasm Transplantation; Neoplastic Cells, Circulating; Nuclear Proteins; Peptides; Pyrroles; Sunitinib; Triple Negative Breast Neoplasms; Twist-Related Protein 1 | 2014 |
Short-term expansion of breast circulating cancer cells predicts response to anti-cancer therapy.
Topics: Antineoplastic Agents; Biomarkers, Tumor; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Female; Gene Dosage; Humans; Indoles; Keratins; MCF-7 Cells; Neoplastic Cells, Circulating; Pyrroles; Spheroids, Cellular; Sunitinib; Treatment Outcome; Tumor Cells, Cultured | 2015 |
Targeting Mutant AKT in Cancer.
Topics: Clinical Trials, Phase I as Topic; Drug Synergism; Estradiol; Fulvestrant; Humans; Mutation; Neoplasms; Neoplastic Cells, Circulating; Precision Medicine; Proto-Oncogene Proteins c-akt; Pyrimidines; Pyrroles; Treatment Outcome | 2016 |
Downsizing a tumor thrombus of advanced renal cell carcinoma with neoadjuvant systemic therapy and resulting histopathological effects.
Topics: Antineoplastic Agents; Carcinoma, Renal Cell; Chemotherapy, Adjuvant; Humans; Indoles; Kidney Neoplasms; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplastic Cells, Circulating; Nephrectomy; Pyrroles; Sunitinib; Thrombectomy; Tomography, X-Ray Computed; Treatment Outcome; Vena Cava, Inferior; Venous Thrombosis | 2010 |
Circulating endothelial cells are an early predictor in renal cell carcinoma for tumor response to sunitinib.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Biomarkers, Tumor; Carcinoma, Renal Cell; Disease-Free Survival; Drug Administration Schedule; Female; Germany; Humans; Indoles; Kaplan-Meier Estimate; Kidney Neoplasms; Male; Middle Aged; Monocytes; Neoplastic Cells, Circulating; Pilot Projects; Protein Kinase Inhibitors; Pyrroles; Sunitinib; Survival Rate; Time Factors; Treatment Outcome; Vascular Endothelial Growth Factor Receptor-2 | 2010 |
Tumor kinase activity in locally advanced rectal cancer: angiogenic signaling and early systemic dissemination.
Topics: Adult; Aged; Analysis of Variance; Bone Marrow Cells; Cell Hypoxia; Female; Humans; Immunomagnetic Separation; Indoles; Male; Middle Aged; Neoplastic Cells, Circulating; Neovascularization, Pathologic; Phosphopeptides; Phosphorylation; Protein-Tyrosine Kinases; Pyrroles; Rectal Neoplasms; Signal Transduction; Sunitinib | 2011 |
Presurgical treatment with sunitinib for renal cell carcinoma with a level III/IV vena cava tumour thrombus.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Carcinoma, Renal Cell; Humans; Indoles; Kidney Neoplasms; Neoplastic Cells, Circulating; Pyrroles; Sunitinib; Vena Cava, Inferior; Venous Thrombosis | 2012 |
Dynamic changes of live/apoptotic circulating tumour cells as predictive marker of response to sunitinib in metastatic renal cancer.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Apoptosis; Biomarkers, Tumor; Disease Progression; Endothelial Cells; Female; Humans; Indoles; Keratin-18; Kidney Neoplasms; Male; Middle Aged; Neoplastic Cells, Circulating; Prospective Studies; Pyrroles; Sunitinib; Treatment Failure | 2012 |
Quantitative relationships between pigment-related mRNA and biochemical melanoma markers in melanoma cell lines.
Topics: Antigens, Neoplasm; Biomarkers, Tumor; Gene Expression Profiling; Humans; Intramolecular Oxidoreductases; MART-1 Antigen; Melanins; Melanoma; Membrane Glycoproteins; Monophenol Monooxygenase; Neoplasm Proteins; Neoplastic Cells, Circulating; Nerve Growth Factors; Oxidoreductases; Pigmentation; Polymerase Chain Reaction; Proteins; Pyrroles; RNA, Messenger; RNA, Neoplasm; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Tumor Cells, Cultured; Tyrosine | 2002 |
Re: Pierre I. Karakiewicz, Nazareno Suardi, Claudio Jeldres, et al. Neoadjuvant Sutent induction therapy may effectively down-stage renal cell carcinoma atrial thrombi. Eur Urol 2008;53:845-8.
Topics: Antineoplastic Agents; Carcinoma, Renal Cell; Heart Diseases; Humans; Indoles; Kidney Neoplasms; Neoadjuvant Therapy; Neoplasm Staging; Neoplastic Cells, Circulating; Pyrroles; Sunitinib; Thrombosis | 2008 |